Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.
about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.Polycystic ovary syndrome in the pediatric populationPerspectives in Polycystic Ovary Syndrome: From Hair to EternityOntogeny of polycystic ovary syndrome and insulin resistance in utero and early childhoodMetabolic features of the reproductive phenotypes of polycystic ovary syndrome.High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review.Establishment of polycystic ovary syndrome-derived human embryonic stem cell lines.Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome.Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels.Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.
P2860
Q21245262-20F75A40-C851-495D-92A2-98E96CAFDBCDQ28390200-26673D9D-E95B-4AF3-999D-00DFE52F6E11Q33750469-10E19C7E-6124-42C6-A2BB-BA8D01D5D145Q35075035-9FFC0A22-4EE0-459C-ACA7-91DCC4BA0C79Q36716040-A18289AB-5302-40B3-8734-845582C73B65Q37067105-B7FBA293-DC85-49E0-8280-FD2851D32081Q37412812-63C5C32A-060E-4F17-BD13-DC31192B9F53Q37417433-6EBF6B79-DF0B-401D-B47B-E601D0762C22Q37515575-FFFB2C29-5D6F-472C-8E42-C792176AB00FQ38861206-0C6F7A3E-9B1F-4C23-9898-040A9EBAA8D2Q39502485-D3D4F1CE-4D7E-4001-AEB4-70487F620B6CQ41108966-33DE3B53-3A48-45C5-A9E1-78D864E0B4FBQ41111951-C662B39E-9CFD-4B54-88A0-0BBCF3B7D712Q42983706-07CE548F-D5B3-4ED4-86D2-92572DD98ABEQ50056205-B6D5E006-5871-4322-AC7E-2833F5AE7827
P2860
Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brothers of women with polycys ...... and related metabolic defects.
@en
Brothers of women with polycys ...... and related metabolic defects.
@nl
type
label
Brothers of women with polycys ...... and related metabolic defects.
@en
Brothers of women with polycys ...... and related metabolic defects.
@nl
prefLabel
Brothers of women with polycys ...... and related metabolic defects.
@en
Brothers of women with polycys ...... and related metabolic defects.
@nl
P2860
P921
P1433
P1476
Brothers of women with polycys ...... and related metabolic defects.
@en
P2093
A C Carpentier
J-P Baillargeon
P2860
P2888
P304
P356
10.1007/S00125-007-0831-9
P577
2007-09-27T00:00:00Z